raloxifene hydrochloride has been researched along with acid phosphatase in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geisert, RD; Morgan, GL; O'Neill, LA; Wettemann, RP; Zavy, MT | 1 |
| Franzson, L; Hansdóttir, H; Prestwood, K; Sigurdsson, G | 1 |
| Inaba, M; Shidara, K | 1 |
| Shimada, H; Takami, M | 1 |
| Dias, SS; Dornelles, RC; Luvizuto, ER; Okamoto, R; Okamoto, T | 1 |
| Bhat, KM; Nampurath, GK; Potu, BK; Rao, MS | 1 |
| Dwivedi, C; Khan, S; Parmar, V; Shirwaikar, A; Srinivasan, KK | 1 |
| Eriguchi, M; Haruyama, N; Kitazono, T; Nakano, T; Tanaka, S; Taniguchi, M; Tsuruya, K; Yamada, S; Yoshida, H | 1 |
| Hirai, K; Inoue, T; Kanehara, H; Nagatoya, K; Nishimoto, K; Okada, S; Shibahara, N; Takahashi, T; Ueda, H; Ueno, N; Yasuda, H | 1 |
2 review(s) available for raloxifene hydrochloride and acid phosphatase
| Article | Year |
|---|---|
[Bone metabolic marker for osteoporosis].
Topics: Acid Phosphatase; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Collagen Type I; Diphosphonates; Female; Fractures, Bone; Humans; Isoenzymes; Osteoporosis; Peptides; Raloxifene Hydrochloride; Risk Assessment; Tartrate-Resistant Acid Phosphatase | 2009 |
[Effects of SERMs on bone health. SERM and metabolic markers of bone].
Topics: Acid Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Humans; Isoenzymes; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tartrate-Resistant Acid Phosphatase | 2010 |
7 other study(ies) available for raloxifene hydrochloride and acid phosphatase
| Article | Year |
|---|---|
Effect of estrogen inhibitors on conceptus estrogen synthesis and development in the gilt.
Topics: Acid Phosphatase; Androstenedione; Animals; Aromatase Inhibitors; Blastocyst; Calcium; Clomiphene; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Embryonic and Fetal Development; Estrogen Antagonists; Estrogens; Female; Least-Squares Analysis; Piperidines; Pregnancy; Pregnancy Proteins; Pregnancy, Animal; Pyrimidines; Raloxifene Hydrochloride; Swine | 1991 |
The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.
Topics: Acid Phosphatase; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Collagen Type I; Data Interpretation, Statistical; Female; Fractures, Bone; Humans; Long-Term Care; Nursing Homes; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphates; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Sex Factors; Time Factors; Vitamin D | 2004 |
Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats.
Topics: Acid Phosphatase; Alveolar Process; Animals; Biomarkers; Bone Density; Bone Density Conservation Agents; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibroblasts; Immunohistochemistry; Isoenzymes; Osteoblasts; Osteoclasts; Osteocytes; Osteoprotegerin; Ovariectomy; Raloxifene Hydrochloride; Random Allocation; RANK Ligand; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tartrate-Resistant Acid Phosphatase; Time Factors; Tooth Extraction; Tooth Socket; Wound Healing | 2011 |
Effect of Cissus quadrangularis Linn on the development of osteopenia induced by ovariectomy in rats.
Topics: Acid Phosphatase; Alkaline Phosphatase; Alkanes; Animals; Biomarkers; Bone Diseases, Metabolic; Bone Resorption; Calcium; Cissus; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Femur; Humans; Hydroxyproline; Isoenzymes; Osteoporosis, Postmenopausal; Ovariectomy; Phytotherapy; Plant Extracts; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Wistar; Tartrate-Resistant Acid Phosphatase | 2011 |
Methanol extract of dried exudate of Commiphora mukul prevents bone resorption in ovariectomized rats.
Topics: Acid Phosphatase; Animals; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcium; Cholesterol; Commiphora; Dose-Response Relationship, Drug; Female; Isoenzymes; Methanol; Ovariectomy; Plant Extracts; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Wistar; Tartrate-Resistant Acid Phosphatase | 2012 |
The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
Topics: Acid Phosphatase; Acute Kidney Injury; Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Cinacalcet; Collagen Type I; Cross-Sectional Studies; Female; Humans; Hydroxycholecalciferols; Isoenzymes; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptides; Peritoneal Dialysis; Raloxifene Hydrochloride; Regression Analysis; Tartrate-Resistant Acid Phosphatase | 2013 |
Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Female; Humans; Isoenzymes; Kidney Failure, Chronic; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Parathyroid Hormone; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Renal Dialysis; Tartrate-Resistant Acid Phosphatase | 2015 |